Skip to main content

Madan Jagasia, M.B.B.S., M.S.

  • Chief Medical Officer, Vanderbilt-Ingram Cancer Center
  • Executive Medical Director, Cancer PCC
  • Co-Leader, Translational Research and Interventional Oncology Research Program
  • Professor of Medicine (Hematology/Oncology)
  • George and Beverly Rawlings Directorship

Phone

(615) 343-5374

Email

madan.jagasia@Vanderbilt.Edu
Division of Hematology/Oncology
3927 The Vanderbilt Clinic
Nashville, TN 37232-5505

Madan Jagasia, M.B.B.S., M.S.

  • Chief Medical Officer, Vanderbilt-Ingram Cancer Center
  • Executive Medical Director, Cancer PCC
  • Co-Leader, Translational Research and Interventional Oncology Research Program
  • Professor of Medicine (Hematology/Oncology)
  • George and Beverly Rawlings Directorship

(615) 343-5374

madan.jagasia@Vanderbilt.Edu

Division of Hematology/Oncology
3927 The Vanderbilt Clinic
Nashville, TN 37232-5505

Profile

Dr. Madan Jagasia, M.B.B.S, M.S., specializes in stem cell transplant for hematological malignancies (leukemia, lymphoma, Myeloma, MDS) and bone marrow disorders. His research interest is graft-versus-host disease, an immune complication after a donor stem cell transplant. He established the long term transplant clinic (LTTC). The goal of this clinic is to provide state-of-the-art care to patients and co-ordinates then care with consultants and the primary referring oncologist. This clinic currently follows more than 500 patients. He is a clinical investigator with a focus on therapy and prevention of acute and chronic GVHD.

Education

  • M.S.C.I., Vanderbilt University, Nashville, Tennessee (2006)
  • M.B.B.S., King Edward Memorial Hospital-College, Mumbai, India (1992)
  • B.S., Ramnarain Ruia College, Mumbai, India (1986)
Postgraduate Training
Internship and Residency
  • King Edward Memorial Hospital (1992 - 1993)
  • Nassau County Medical Center (1993 - 1994)
  • University of Tennessee, Methodist Hospital (1994 - 1996)
Fellowship in Hematology/Oncology
  • Vanderbilt University (1998 - 2001)

Research Emphasis

Stem cell transplant, leukemia, lymphoma, myeloma

Research Description

Clinical trials in GVHD, new drugs in leukemia, lymphoma and myeloma. Novel preparative regimen for stem cell transplant.

Publications

Have any questions? Contact Us 1-877-936-8422 for more information